Objective: The objective of this study was to identify potential risk factors for mortality and morbidity after distal pancreatectomy, with special focus on the formation of pancreatic fistula. Summary Background Data: Distal pancreatectomy can be performed with low mortality and acceptable morbidity rates. Pancreatic fistulas, occurring in 10% to 20% of cases, remain a problem that contributes significantly to morbidity, length of stay, and overall costs. Methods: From November 1993 to February 2006, perioperative and postoperative data of 302 consecutive patients were recorded. Univariate and multivariate analyses of potential risk factors for morbidity and for the formation of pancreatic fistula were performed. The surgical techniques used for closure were categorized into 4 groups: 1) anastomosis, 2) seromuscular patch, 3) closure by suture, and 4) closure using a stapling device. Results: Indications for resection were pancreatic tumors in 62% of patients, nonpancreatic tumors in 23%, chronic pancreatitis in 12%, and others in 3%. The spleen was preserved in 24% of patients. The morbidity and mortality rates for distal pancreatectomy in this series were 35% and 2%, respectively. The prevalence of pancreatic fistula was 12%. Univariate and multivariate analyses indicated that closure using a stapling device and an operating time Ն480 minutes were associated with a higher incidence of pancreatic fistula (odds ratio ϭ 2.6 and 4.2, respectively). Overall morbidity was mainly influenced by the extent of resection (multivisceral vs. conventional; odds ratio ϭ 1.7). Conclusion: Pancreatic leak remains a common complication after distal pancreatectomy. Our series suggests that stapler closure of the pancreatic remnant is associated with a significantly higher fistula rate.
T he surgical procedure of choice for benign or malignant lesions in the body or tail of the pancreas is the distal pancreatectomy. This operation entails the removal of the portion of the pancreas extending to the left of the midline and not including the duodenum and distal bile duct. The pancreas is usually divided to the left of the superior mesenteric vein/portal vein trunk, with the exact line of transection depending on the location of the lesion. Because of the lower incidence of pancreatic disease and later appearance of clinical symptoms in this part of the organ, distal pancreatectomies are performed less often than resections of the pancreatic head. 1 In the past decade, advances in surgical technique have reduced the operative mortality rate of pancreatic resections to below 5% in high-volume centers, 2-8 yet morbidity rates have remained essentially unchanged, ranging from 30% to 40%. [3] [4] [5] 7, 8 Pancreatic fistula is a main cause of postoperative morbidity and is associated with numerous further complications, such as intra-abdominal abscesses, wound infection, sepsis, electrolyte imbalance, malabsorption, and hemorrhage, 9 and with a dramatically increase in healthcare resource utilization. 10 In general, the surgical technique and the surgeon are considered the most relevant risk factors for fistula formation. Several surgical resection and closure techniques have been introduced for the pancreatic remnant in an attempt to reduce complications, and in particular pancreatic fistulas. These include hand-sewn suture techniques, stapled closure techniques, or a combination of both [11] [12] [13] [14] [15] [16] ; ultrasonic dissection devices, 17 pancreaticoenteric anastomosis, 18 application of meshes, seromuscular 19 and gastric serosa patches, 20 or sealing with fibrin glue. 21, 22 The objective of this study was to analyze factors contributing to postoperative mortality and morbidity following distal pancreatectomy. Thus, univariate and multivariate analyses were carried out to identify potential risk factors for morbidity, and specifically for the formation of pancreatic fistulas, with special emphasis on the used closure techniques.
PATIENTS AND METHODS
Data were prospectively collected in an electronic database from November 1993 through February 2006 for all patients undergoing distal pancreatectomy. The first database was established at the Department of Visceral and Transplan-tation Surgery (University of Bern, Switzerland; November 1993 to September 2001), and the second database at the Department of General Surgery (University of Heidelberg, Germany; October 2001 to February 2006). Data were collected on standardized data sheets for all patients undergoing pancreatic resection or explorative/palliative procedures for pancreatic/peripancreatic diseases. The variables were grouped into demographics, indications, preoperative evaluation and risk assessment, operation, and postoperative course. The present analysis includes in-hospital data for all patients (n ϭ 302) undergoing distal pancreatectomy over a 13-year period.
Standard Treatment Protocols
Almost all the patients underwent contrast-enhanced abdominal computed tomography or magnetic resonance imaging with cholangiopancreaticography (MRCP) as the standard preoperative investigation. The preoperative risk was graded according to the American Society of Anesthesiologists (ASA) classification. All patients received prophylactic antibiotics perioperatively together with a daily dose of subcutaneous low molecular weight heparin. All patients received prophylactic subcutaneous octreotide (Sandostatin, Novartis Pharma GmbH, Nürnberg, Germany), beginning with the first dose of 200 g given at induction. The postsurgical regimen was 3 daily doses of 200 g octreotide for the next 5 days. Nasogastric suction tubes were placed during the operation and routinely removed after extubation. Two passive-drainage tubes (Easy-flo, Dahlhausen & Co. GmbH, Cologne, Germany), one in the pelvis and the other in close proximity to the pancreatic remnant, were routinely placed during the operation and removed after 1 to 3 days (depending on the volume and content). Perioperative and postoperative pain management included epidural anesthesia or patient-controlled analgesia in all patients. After the operation, patients were transferred to the intensive care unit overnight or to an intermediate care unit. All complications were recorded prospectively in the database. The mortality rate was defined as the total in-hospital death rate. Delayed gastric emptying (DGE) was defined as a nasogastric tube for more than 10 days after surgery, inability to proceed to a regular diet within 10 days, or vomiting for more than 3 consecutive days after the fifth postoperative day. 3, 23 A pancreatic fistula was defined as secretion of 30 mL or more of amylase-rich drainage fluid (Ͼ5000 units) per day for more than 10 days, or the necessity for interventional draining of an amylase-rich fluid collection. 24 Pancreatic fistulas were graded according to the recent international fistula definition. 25 
Surgical Technique
Following a thorough examination of the peritoneal cavity, the gastrocolic ligament was divided to allow full visualization of the pancreas to its tail and the hilum of the spleen. Care was taken to preserve the short gastric vessels and the gastroepiploic arcade. The point of division was selected in the proximal normal pancreas, and stay sutures were then placed on either side of the planned transection line on both the superior and inferior borders. A plane was then developed posterior to the pancreas by blunt dissection, aided by upwards tension on the stay sutures, until the splenic vein was identified ( Fig. 1 ). If problems in identifying the splenic vein were encountered, the splenic vein-portal vein junction under the pancreatic neck was identified. The splenic artery can usually be located along the superior border of the pancreas. The artery and the vein were then individually encircled with vascular loops. Following vascular control, the pancreas was divided. Splenic preservation was attempted in patients with benign lesions or borderline tumors (eg, cystic neoplasm; Fig. 1 ), but not for pancreatic adenocarcinoma. 26, 27 Lymphadenectomy was performed when the indication for the operation was a malignant tumor and the operation would involve the excision of the nodal tissues along the common hepatic artery, the left gastric artery and the celiac axis, and along the superior mesenteric vein, as well as the peripancreatic lymph nodes. Extended, ie, multivisceral, resections were carried out in case of contiguous organ involvement. 28 Four main surgical techniques were used for transection and closure of the pancreatic remnant:
1. Anastomosis: The pancreaticojejunal end-to-side anastomosis was carried out as described previously. 24 2. Seromuscular patch: A seromuscular patch was placed in one layer on both sides of the transection line to the gastric wall or jejunum to cover the cut and closed edge of the pancreas (closed by suture or stapler). Single stitches of 4-0 or 5-0 PDS (Ethicon Endo-surgery, Johnson & Johnson, Cincinnati, OH) were made every 6 to 8 mm, taking care to avoid tension on the suture line. 3. Closure by suture: The pancreas was transected with a knife, followed by identification of the main pancreatic duct and closure of the duct using single stitches of 4-0 or 5-0 PDS. The parenchyma was then closed using single stitches of 4-0 or 5-0 PDS ( Fig. 2a ). In some cases, the suture line was reinforced by laying a fibrinogen/thrombin-coated collagen patch (TachoSil, Nycomed Pharma, Unterschleissheim, Germany) onto the transected end. 4. Closure using a stapling device: The pancreas was transected with a linear stapling device, using the ETS Flex 45 cutter with a white vascular cartridge (Ethicon Endo-surgery) ( Fig. 1 ). This device gives a staple line consisting of a double row of closely placed staples ( Fig. 2b ). Occasionally, depending on the texture of the pancreas and on the discretion of the surgeon, blue or green cartridges were used. In some cases, the staple line was reinforced by laying a fibrinogen/thrombin-coated collagen patch (TachoSil) onto the transected end (Fig. 2c ).
The indication for performing an anastomosis was suspected or proven duct obstruction toward the duodenum (in most cases, proximal duct obstruction was suspected preoperative; in some cases, however, it was suspected only intraoperative, eg, after knife transection and cannulation of the pancreatic duct). Indications for use of the patch, suturing, or stapling depended on the texture of the gland and the personal preference of the surgeon. All procedures were carried out by experienced senior surgeons.
Management of the Persistent Pancreatic Fistula
There was no standard treatment protocol for pancreatic fistula. In general, drains were left in place, or (in the case of early drain removal) interventional drains were placed. According to the standard protocol, 200 g octreotide were given 3 times per day for 5 days postoperative. In some cases, especially when the fistula developed within the first 5 postoperative days, octreotide was continued for up to 2 to 3 weeks (depending on the clinical course). In general, oral food intake was not stopped. In addition, ERCP was neither used preoperative as a prophylactic measure or postoperative as a treatment technique in patients with pancreatic fistulas. Thus, the basic principle of therapy was adequate drainage (and patience).
Statistics
SAS software (Release 9.1, SAS Institute, Inc., Cary, NC) was used for statistical analysis. Descriptive statistics of the quantitative parameters age at operation and postoperative hospital stay as well as the intraoperative parameters blood 
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Distal Pancreatectomy loss and operative time are presented as median with interquartile range (IQR). Fisher exact test was applied to compare subgroups of patients according to the closure technique and the extent of resection. Blood loss and operative time were compared among the groups using the Kruskal-Wallis test and the Mann-Whitney U test. Study endpoints for the risk factor analysis were surgical morbidity and the development of a pancreatic fistula. Logistic regressions were performed for univariate and multivariate analysis of parameters potentially associated with study endpoints. The relative risk was described by the estimated odds ratio (OR) with a 95% confidence interval. Two-sided P values were always computed and an effect was considered statistically significant at P Յ 0.05. The median age of the patients undergoing distal pancreatectomy was 61 years, with a range of 14 to 87 years, and there were 148 female and 154 male patients ( Table 1 ). The main indications for distal pancreatectomy were tumors, in 84.8%. Of these, 61.6% (n ϭ 186) were benign or malignant pancreatic tumors and 23.2% (n ϭ 70) were other tumors (metastasis or direct infiltration). Chronic pancreatitis was an indication in 11.9% (n ϭ 36), and others in 3.3% (n ϭ 10) ( Table 1) . Splenectomy was carried out in 76.5% of the cases (n ϭ 231). Although endoscopies were not performed routinely during follow-up, there was no case of gastric or esophageal variceal bleeding in patients with spleen-preserving distal pancreatectomy. Multivisceral resections (including colon, kidney, liver, adrenal gland, stomach) were performed in 36.1% (n ϭ 109). The extent of multivisceral resections is given in Table 2 . In 31.2% (n ϭ 34) of the multivisceral resections, 2 or more organs were affected.
RESULTS

Between
Cases were divided into 4 groups, according to the closure technique. A pancreatic anastomosis (technique as described in 24 ) was carried out in 24 patients (8%) who had signs of obstruction of the pancreatic duct toward the papilla of Vater. In 36 cases (11.9%), the cut end of the pancreas (either closed by suturing or stapling) was covered by a seromuscular patch (small bowel or stomach). The pancreatic remnant was closed with endovascular stapling in 145 patients (48.0%) and sutures in 97 patients (32.1%), as described in Methods. In most cases, the closed remnant was covered either by omentum or by a fibrin sealant (TachoSil) ( Table 1) .
The median operative time was 245 minutes (IQR, 185-330 minutes). The shortest median operating time was observed in the stapling group, with 210 minutes (IQR, 165-290 minutes) (P Ͻ 0.0001). Interestingly, median operating times between the anastomosis, seromuscular patch, and suture groups were not significantly different (IQR, 270 -300 minutes) (P ϭ 0.5658) ( Table 3 ). Not surprisingly, taking into account the extent of resection, multivisceral resections had the longest operating time (310 minutes; IQR, 245-390 minutes) (P Ͻ 0.0001), whereas there was no significant difference between the spleen-preserving and the splenectomy groups, with median operating times of 200 and 220 minutes, respectively (P ϭ 0.1514) ( Table 4 ). Median blood loss was 700 mL (IQR, 400 -1200 mL). Median blood loss was higher in the anastomosis and suture groups (1000 mL) compared with the seromuscular patch and stapling groups (both 500 mL) (P Ͻ 0.0001). In the multivisceral group, the median blood loss of 1000 mL (IQR, 500 -1800) was higher than in the spleen-preserving and splenectomy groups (both 500 mL) (P Ͻ 0.0001).
The overall morbidity in this series was 35.4%, with a medical morbidity of 13.6% and a surgical morbidity of 27.2%. Pancreatic fistulas developed in 11.6% of the patients (n ϭ 35). According to the recent fistula definition, 25 0 fistulas were classified as grade A, 27 as grade B, and 8 as grade C. Median fistula volume was 400 mL (IQR, 150 -700 mL) and median amylase and lipase levels were 4216 U/L (IQR, 483-19,153 U/L) and 20,478 U/L (IQR, 667-34,535 U/L), respectively (fistula volume and amylase content represent maximal values for each patient). Median length of time to resolution of pancreatic fistula was 38 days (IQR, 21-56 days). Intra-abdominal abscess formation occurred in 5.0% of patients, delayed gastric emptying in 4.6%, bleeding in 3.3%, and wound infection in 2.7%. There was a striking difference in the fistula rate between the different groups, with no pancreatic fistulas in the anastomosis group, a rate of 8.3% in the seromuscular patch group, and a rate of 9.3% in the suture group. The highest fistula rate was observed in the stapler group, with 15.9% (P ϭ 0.0308). In addition to the closure technique, the extent of resection influenced the fistula rate. The fistula rate in the spleen-preserving group was 5.1%. In contrast, in the splenectomy and multivisceral groups the fistula rates were 11.2% and 15.6%, respectively (P ϭ 0.0480). The relaparotomy rate in our series was 8.6%, with postoperative bleeding and pancreatic fistula/abscess formation being the most frequent indications for reoperation. There was an increase in the reoperation rate without a change in the indication for reoperations over time ( Table 5 ). The reasons for this increase might include more aggressive multivisceral resections, more surgeons in training, and a lower threshold for reoperations; 79.3% of the patients stayed 2 days or fewer in the intensive care unit. The median hospital stay was 12 days (IQR, 9 -16 days). The mortality rate in this series was 2.0% (n ϭ 6; 4 patients died of multiorgan failure due to intraabdominal sepsis and 2 patients died of septic intraabdominal hemorrhage). There was a significant difference in the mortality rate between multivisceral resections (mortality, 5.5%) and distal pancreatectomies without multivisceral resection (zero mortality) (P ϭ 0.002) ( Tables 3, 4 ).
Univariate and multivariate analyses were carried out to identify risk factors associated with morbidity (especially pancreatic fistula) following distal pancreatectomy. Univariate logistic regression analysis regarding morbidity indicated that several factors were associated with increased morbidity, although neither factor achieved statistical significance ( Table 6 ). Thus, for example, patients older than 70 years had a 1.75-fold increased morbidity rate (P ϭ 0.15). In addition, intraoperative blood loss of more than 2000 mL was associated with a 1.5-fold increase in morbidity (P ϭ 0.32), and an operative time longer than 480 minutes was associated with a 2.3-fold increase (P ϭ 0.10). Notably, the extent of resection also had an influence (P ϭ 0.08), with multivisceral resections having a 1.9-fold increased morbidity rate. Similarly, the type of closure had an effect (P ϭ 0.19), with both seromuscular patch and stapler closure increasing morbidity (2.2-fold and 1.7-fold, respectively). Multivariate analysis of morbidity indicated that multivisceral resection (OR, 1.68; P ϭ 0.051) and stapler/patch closure (OR, 1.76; P ϭ 0.042) were associated with increased morbidity following distal pancreatectomy ( Table 7) .
Univariate logistic regression analysis also revealed several factors that were associated with an increased risk of developing pancreatic fistulas (Table 8 ). Patients younger than 50 years had a decreased pancreatic fistula risk (OR, 0.337; P ϭ 0.04), whereas an operative time of 480 minutes or longer was associated with an increased risk (OR, 3.25; P ϭ 0.046). The extent of resection also influenced the risk of developing a pancreatic fistula, with an OR of 3.45 for multivisceral resection and 2.35 for splenectomy, although these effects were not significant. Most interestingly, however, closure of the pancreatic remnant using a stapling device was associated with a significantly (P ϭ 0.031) increased risk of developing a pancreatic fistula (OR, 2.28; 95% confidence interval, 1.11-4.91). Multivariate analysis regarding pancreatic fistula confirmed closure technique, operation time, and patient age as independent risk factors (Table 9 ).
DISCUSSION
Management of the pancreatic remnant following distal pancreatectomy remains a clinically relevant problem. From a surgical point of view, pancreatic fistula in particular is an unsolved problem, inasmuch as several technical variations have failed to significantly reduce its incidence. 16 Today, this procedure-specific complication, which has not significantly decreased over recent years, is treated conservatively or by interventional radiology in the majority of patients. If treated in a timely fashion, these complications do not lead to mortality. Nonetheless, pancreatic fistula formation is a major source of morbidity, and associated complications such as abscess, hemorrhage, sepsis, and DGE may result in considerable healthcare expenditures. 10, 14 A recently published systematic review appraised all available surgical alternatives for handling the pancreatic remnant after distal pancreatectomy. 9 These different techniques, such as duct ligation, ultrasonic dissection, the use of fibrin glue, patches and meshes, pancreaticoenteric anastomosis, and hand-sewn and stapler closure, reflect the clinical heterogeneity in this field. 9 However, the impact of these techniques is hard to interpret owing to small sample size, nonrandomized study design, and inconsistent study population and fistula definition.
Our report presents the largest consecutive series of distal pancreatectomies. Compared with other large series, 29 we specifically focused on factors contributing to pancreatic fistula. One obvious advantage is that, since the same team performed these operations, a comparison between different techniques is more reliable (due to surgical standardization) than a comparison of different techniques that are carried out at different institutions.
There are several potential factors that influence the occurrence of pancreatic fistulas after distal pancreatectomy: 
Duct Obstruction
If there is obstruction of the pancreatic duct in the pancreatic head/periampullary region, there is increased pressure on the cut end of the pancreatic duct, with increased likelihood of fistula. Clearly, in instances of duct obstruction in the head region, the pancreatic remnant should be anastomosed. Thus, in the present series, suspected or proven duct obstruction was an indication to perform an anastomosis.
However, it cannot be excluded that obstructed outflow of the pancreatic juice toward the ampulla and subsequent increased pressure contributed to some of the fistulas observed in the groups without pancreatic anastomosis.
Pancreatic anastomosis is the safest method of closure of the pancreatic remnant following distal pancreatectomy (in our series, there were no fistulas and no mortality). However, one could speculate that pancreatic leakage following small bowel anastomosis could result in potentially more hazardous complications than leakage without anastomosis (activation of pancreatic enzymes, bacterial contamination, etc). Therefore, a pancreatic anastomosis following distal pancreatectomy should only be performed if it can be carried out safely. Another potential drawback would be a longer operating time, yet compared with closure by suture or seromuscular patch, there was no significant difference (270 minutes vs. 273-300 minutes) in median operating times in our series. However, closure by stapler alone was 1 hour faster (median 
Technical
Clearly, in the case of stapling, if pancreatic sutures are torn out or tissue tears, at least parts of the pancreatic parenchyma are not "sealed" and leakage can occur. While there were no obvious technical problems in the present series, it is likely that some of the mechanisms described above contributed to the observed fistula rate. When sutures are used, it is generally obvious if there is tearing, especially of the duct sutures. This is not always the case with stapling. In some instances, especially with a small eccentric located duct, it might be possible that breaking of the pancreas in the area of the duct will go unnoticed. The significantly higher incidence of fistula formation using stapler devices (15.9% vs. 9.3%) might reflect this problem.
Anatomic
In the current series, the fistula rate was between 8.3% and 15.9% for the different techniques employed (without anastomosis). These results are consistent with published data and suggest that technical causes alone cannot be responsible for pancreatic fistula after distal pancreatectomy. It is tempting to speculate that anatomic variations account for a large share of pancreatic fistulas. There may be areas of pancreatic parenchyma near the cut surface whose ducts are cut and therefore cannot drain into the main pancreatic duct. These obstructed areas most likely develop focal necrotizing pancreatitis and give rise to transient pancreatic fistulas. Although there is no direct proof for this hypothesis, anatomic data support this. 30 The use of a seromuscular pancreatic patch to prevent postoperative pancreatic fistula formation was first described by Moriura et al 19 in 1995. Kluger et al 20 reported its application in 1997 in trauma patients with pancreatic injury. Placement of a seromuscular patch between the distal cut edge of the pancreas and the posterior gastric wall or the small intestine is a fast, technically feasible procedure and is cost-effective when compared with various sealants that are currently available. However, in the present series, this technique had a major drawback, ie, an increased rate of DGE. The reason for the significantly increased DGE rate in the seromuscular patch group (13.9% vs. 3.4%) is not readily apparent. It could be speculated that small (clinically inapparent) pancreatic leaks result in local irritation of the stomach and/or small bowel and trigger subsequent delayed gastric emptying. Indeed, it has been shown recently for pancreaticoduodenectomies that a greater distance between the pancreatic anastomosis and the stomach/small bowel (ie, antecolic vs. retrocolic duodenojejunostomy) results in a significant decrease of the delayed gastric emptying rate. 23, 31 Clearly, covering of the pancreatic remnant with a seromuscular patch, although associated with a somewhat lower fistula rate (8.3% in this series), cannot be recommended due to the high DGE rate.
Multivisceral resections were associated with increased blood loss (1000 mL vs. 500 mL), increased fistula rate (15.6% vs. 9.3%), increased hospital stay (13 days vs. 10 -11 days), and increased mortality (5.5% vs. 0.0%). While it might be expected that more extensive surgery results in more blood loss, longer hospital stay, and increased mortality, the increase in fistula rate is somewhat surprising. It might be speculated that extensive (ie, multivisceral) resections compromise healing of the pancreatic remnant. Another possible explanation could be a reduced blood supply at the cut surface of the pancreas due to the extent of the resection. In line with this hypothesis, it has been shown that blood supply at the cut surface of the pancreas is also an important factor for pancreatic fistula after pancreaticoduodenectomy. 32 However, although there was a tendency toward a higher fistula rate, our multivariate analysis indicated that multivisceral resections were not significantly associated with an increased risk of developing a pancreatic fistula.
Although in the present series all resections were performed during open laparotomy, there is a clear tendency to perform this operation with laparoscopic techniques. This approach, however, shares the same specific problems, ie, the formation of pancreatic fistula. [33] [34] [35] Clearly, closure of the pancreatic remnant is also an important issue for laparoscopic distal pancreatectomy, and the same considerations should apply to the laparoscopic and the open approach. Currently, stapler transection is the preferred method during laparoscopic distal pancreatectomy, an approach that has to be critically evaluated in light of the current data.
CONCLUSION
Closure of the pancreatic remnant using a stapling device was associated with a significantly higher fistula rate in this series of distal pancreatectomies, the largest series reported to date. Especially with respect to the data from a recent meta-analysis, 9 there is clearly the need for a randomized controlled trial to determine the best closure technique. Our department is currently preparing for such a trial. 9 
